Safety and effectiveness of BufferGel and 0.5% PRO2000 gel for the prevention of HIV infection in women (Q34874237)

5 August 2017

Safety and effectiveness of BufferGel and 0.5% PRO2000 gel for the prevention of HIV infection in women (English)

1 reference

5 August 2017

prevention of HIV/AIDS

0 references

1 reference

3

Gita Ramjee

1 reference

5 August 2017

Taha Taha

6

0 references

Salim Abdool Karim

object named as

Salim S Abdool Karim

1

0 references

Estelle Piwowar-Manning

12

object named as

Estelle Piwowar-Manning

1 reference

5 August 2017

5

Zvavahera M Chirenje

1 reference

5 August 2017

2

Barbra A Richardson

1 reference

5 August 2017

14

Sharon L Hillier

1 reference

5 August 2017

Irving F Hoffman

4

1 reference

5 August 2017

Muzala Kapina

7

1 reference

5 August 2017

Lisa Maslankowski

8

1 reference

5 August 2017

Anne Coletti

9

1 reference

5 August 2017

Albert Profy

10

1 reference

5 August 2017

Thomas R Moench

11

1 reference

5 August 2017

Benoît Mâsse

13

1 reference

5 August 2017

Lydia Soto-Torres

15

1 reference

5 August 2017

HIV Prevention Trials Network (HPTN) 035 Study Team

16

1 reference

5 August 2017

language of work or name

English

0 references

publication date

1 April 2011

1 reference

5 August 2017

1 reference

5 August 2017

25

1 reference

5 August 2017

957-966

1 reference

5 August 2017

7

1 reference

PRO2000 vaginal gel for prevention of HIV-1 infection (Microbicides Development Programme 301): a phase 3, randomised, double-blind, parallel-group trial

5 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3083640

Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3083640

Limitations of the dye-based method for determining vaginal applicator use in microbicide trials

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3083640

Lack of effectiveness of cellulose sulfate gel for the prevention of vaginal HIV transmission

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3083640

SAVVY vaginal gel (C31G) for prevention of HIV infection: a randomized controlled trial in Nigeria

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3083640

Phase I safety study of 0.5% PRO 2000 vaginal Gel among HIV un-infected women in Pune, India

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3083640

Low pH immobilizes and kills human leukocytes and prevents transmission of cell-associated HIV in a mouse model.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3083640

Effectiveness of COL-1492, a nonoxynol-9 vaginal gel, on HIV-1 transmission in female sex workers: a randomised controlled trial

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3083640

Effect of nonoxynol-9 gel on urogenital gonorrhea and chlamydial infection: a randomized controlled trial

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3083640

'Chemical condoms' for the prevention of HIV infection: evaluation of novel agents against SHIV(89.6PD) in vitro and in vivo.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3083640

Tests of Buffergel for contraception and prevention of sexually transmitted diseases in animal models.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3083640

Phase 1 trial of the topical microbicide BufferGel: safety results from four international sites

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3083640

Safety and tolerability of BufferGel, a novel vaginal microbicide, in women in the United States

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3083640

A phase I study of a novel potential intravaginal microbicide, PRO 2000, in healthy sexually inactive women

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3083640

The effectiveness of condoms in reducing heterosexual transmission of HIV.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3083640

A controlled trial of nonoxynol 9 film to reduce male-to-female transmission of sexually transmitted diseases

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3083640

Female-controlled methods to prevent sexual transmission of HIV.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3083640

Efficacy of nonoxynol 9 contraceptive sponge use in preventing heterosexual acquisition of HIV in Nairobi prostitutes

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3083640

Efficacy of Carraguard for prevention of HIV infection in women in South Africa: a randomised, double-blind, placebo-controlled trial.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3083640

Some design issues in trials of microbicides for the prevention of HIV infection

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3083640

Safety and tolerability of vaginal PRO 2000 gel in sexually active HIV-uninfected and abstinent HIV-infected women.

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3083640

Acceptability of a novel vaginal microbicide during a safety trial among low-risk women

26 October 2018

1 reference

12 December 2020

Sensitivity of non-clade B primary HIV-1 isolates to mildly acidic pH

1 reference

12 December 2020

The rate at which human sperm are immobilized and killed by mild acidity

1 reference

12 December 2020

Evaluation of a low-dose nonoxynol-9 gel for the prevention of sexually transmitted diseases: a randomized clinical trial

1 reference

12 December 2020

In vitro and in vivo characterization of a potential universal placebo designed for use in vaginal microbicide clinical trials

1 reference

12 December 2020

Challenges for the development of female-controlled vaginal microbicides

1 reference

12 December 2020

10.1097/QAD.0B013E32834541D9

Identifiers

DOI

1 reference

5 August 2017

1 reference

5 August 2017

1 reference